Geode Capital Management »

Transcode Therapeutics shares owned by Geode Capital Management

Quarter-by-quarter ownership of Transcode Therapeutics (RNAZ) shares owned by Geode Capital Management from 13F filings

Historical chart of Geode Capital Management investment in Transcode Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Transcode Therapeutics held by Geode Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Transcode Therapeutics by Geode Capital Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $70k 122k 0.57
2024-06-30 $39k 38k 1.01